Skip to main content

$0.440 (0%)

High

$0.44

Low

$0.44

Trades

1

Turnover

$8,800

Volume

20,000
30 June 2023 at 3:50pm
Register to track VBS and receive email alerts.
Subject
VBS Ann: Preliminary Final Report - Appendix 4E

VBS Ann: Completion of Second M.A.D. Study for VB0004

VBS Ann: Quarterly Activities Report & Appendix 4C

VBS Ann: Issue of Shares & Cleansing Notice

VBS Ann: Notification of cessation of securities - VBS

VBS Ann: Application for quotation of securities - VBS

VBS Ann: Issue of Shares & Appointment of Advisor in China

VBS Ann: Notification regarding unquoted securities - VBS

VBS Ann: Completion of Final S.A.D. Study and First M.A.D. Study

VBS Ann: Issue of Shares - Appendix 2A

VBS Ann: Quarterly Activities/Appendix 4C Cash Flow Report

VBS Ann: Issue of Shares - Appendix 2A

VBS Ann: Half Yearly Report and Appendix 4D

VBS Ann: A Significant Milestone for VB0004

VBS Ann: Becoming a substantial holder

VBS Ann: Appendix 2A - Issue of Shares

VBS Ann: Quarterly Activities/Appendix 4C Cash Flow Report

VBS Ann: Results of Annual General Meeting

VBS Ann: Chairman & CEO Address to Shareholders

VBS Ann: Notice of Annual General Meeting / Proxy Form

VBS Ann: Date of Annual General Meeting

VBS Ann: Third S.A.D. Group Reviewed By Trial Safety Review Committee

VBS Ann: Change of Director's Interest Notice - RS

VBS Ann: Appendix 2A - Issue of Shares

VBS Ann: Investor Webinar

VBS Ann: Progress Presentation

VBS Ann: Quarterly Activities Report & Appendix 4C

VBS Ann: Corporate Governance Statement & Appendix 4G

VBS Ann: Annual Report to shareholders

VBS Ann: Response to ASX Price and Volume Query

VBS Ann: Appendix 2A - Issue of Shares

VBS Ann: Broker Briefing Investor Webinar

VBS Ann: Update on Phase I Human Trial

VBS Ann: Full Year Statutory Accounts

VBS Ann: Preliminary Final Report - Appendix 4E

VBS Ann: Progress Presentation

VBS Ann: Successful Completion of First Group in Phase I Human Trial

VBS Ann: Quarterly Activities Report & Appendix 4C

VBS Ann: Approval Received for Phase I Trial in Australia

VBS Ann: Appendix 3G - Issue of Options under EIP

VBS Ann: Quarterly Activities Report & Appendix 4C

VBS Ann: Half Yearly Report and Appendix 4D

VBS Ann: Quarterly Activities Report & Appendix 4C

VBS Ann: Issue of Placement Shares - Appendix 2A

VBS Ann: Results of Annual General Meeting

VBS Ann: Chairman & CEO Address to Shareholders

VBS Ann: Proposed issue of Securities - VBS

VBS Ann: Vectus completes $7 million placement

VBS Ann: Trading Halt

VBS Ann: Notice of Annual General Meeting / Proxy Form

Register to track VBS and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
MSB
TLX